Mark Kessel
Chairman at Symphony ViDA, Inc.
Mark Kessel active positions
| Companies | Position | Start | End |
|---|---|---|---|
Symphony Dynamo, Inc.
 Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Director/Board Member | - | - |
Symphony ViDA, Inc.
 Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Chairman | 02/03/2011 | - |
| Director/Board Member | - | 02/03/2011 | |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - | - |
| Fondation Santé | Director/Board Member | - | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - | - |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Chairman | - | - |
Career history of Mark Kessel
Former positions of Mark Kessel
| Companies | Position | Start | End |
|---|---|---|---|
| ORGANOVO HOLDINGS, INC. | Director/Board Member | 17/08/2016 | 15/09/2020 |
| Independent Dir/Board Member | 17/08/2016 | 15/09/2020 | |
Shearman & Sterling LLP
 Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1971 | 30/06/2019 |
| ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 22/10/2008 | 09/09/2011 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░ ░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Mark Kessel
| Syracuse University College of Law | Graduate Degree |
| The City College of New York | Undergraduate Degree |
Statistics
International
| United States | 17 |
| Greece | 2 |
| Switzerland | 2 |
Operational
| Director/Board Member | 10 |
| Chairman | 4 |
| Founder | 2 |
Sectoral
| Health Technology | 12 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| AGENUS INC. | Health Technology |
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Health Technology |
Shearman & Sterling LLP
Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Commercial Services |
Symphony Dynamo, Inc.
Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Health Technology |
Symphony Genisis, Inc.
 Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Health Technology |
Symphony Icon, Inc.
 Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Health Technology |
Symphony Neuro Development Co.
 Symphony Neuro Development Co. Pharmaceuticals: MajorHealth Technology Symphony Neuro Development Co. manufactures pharmaceuticals. It is engaged in the research, development, and commercialization of proprietary drugs that target the hospital and neurology markets. The company is headquartered in Rockville, MD. | Health Technology |
Symphony Capital LLC
 Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Finance |
| Fondation Santé | |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Foundation for Innovative New Diagnostics
Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Health Services |
- Stock Market
- Insiders
- Mark Kessel
- Experience
